Publication: Efficacy and safety of fosfomycin plus imipenem versus vancomycin for complicated bacteraemia and endocarditis due to methicillin-resistant Staphylococcus aureus: a randomized clinical trial.
dc.contributor.author | Pericàs, J M | |
dc.contributor.author | Moreno, A | |
dc.contributor.author | Almela, M | |
dc.contributor.author | García-de-la-Mària, C | |
dc.contributor.author | Marco, F | |
dc.contributor.author | Muñoz, P | |
dc.contributor.author | Peña, C | |
dc.contributor.author | de Alarcón, A | |
dc.contributor.author | Del Río, A | |
dc.contributor.author | Eworo, A | |
dc.contributor.author | Cruceta, A | |
dc.contributor.author | Paré, J C | |
dc.contributor.author | Mestres, C A | |
dc.contributor.author | Miró, J M | |
dc.contributor.author | FOSIMI Investigators | |
dc.date.accessioned | 2023-01-25T10:03:25Z | |
dc.date.available | 2023-01-25T10:03:25Z | |
dc.date.issued | 2018-02-03 | |
dc.identifier.doi | 10.1016/j.cmi.2018.01.010 | |
dc.identifier.essn | 1469-0691 | |
dc.identifier.pmid | 29408610 | |
dc.identifier.unpaywallURL | http://www.clinicalmicrobiologyandinfection.com/article/S1198743X18300648/pdf | |
dc.identifier.uri | http://hdl.handle.net/10668/12088 | |
dc.issue.number | 6 | |
dc.journal.title | Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases | |
dc.journal.titleabbreviation | Clin Microbiol Infect | |
dc.language.iso | en | |
dc.organization | Instituto de Biomedicina de Sevilla-IBIS | |
dc.organization | Hospital Universitario Virgen del Rocío | |
dc.page.number | 673-676 | |
dc.pubmedtype | Case Reports | |
dc.pubmedtype | Letter | |
dc.pubmedtype | Multicenter Study | |
dc.pubmedtype | Randomized Controlled Trial | |
dc.rights.accessRights | open access | |
dc.subject.mesh | Aged | |
dc.subject.mesh | Aged, 80 and over | |
dc.subject.mesh | Anti-Bacterial Agents | |
dc.subject.mesh | Bacteremia | |
dc.subject.mesh | Endocarditis | |
dc.subject.mesh | Female | |
dc.subject.mesh | Fosfomycin | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Imipenem | |
dc.subject.mesh | Male | |
dc.subject.mesh | Methicillin-Resistant Staphylococcus aureus | |
dc.subject.mesh | Microbial Sensitivity Tests | |
dc.subject.mesh | Middle Aged | |
dc.subject.mesh | Treatment Outcome | |
dc.subject.mesh | Vancomycin | |
dc.title | Efficacy and safety of fosfomycin plus imipenem versus vancomycin for complicated bacteraemia and endocarditis due to methicillin-resistant Staphylococcus aureus: a randomized clinical trial. | |
dc.type | research article | |
dc.type.hasVersion | VoR | |
dc.volume.number | 24 | |
dspace.entity.type | Publication |